HomeCompareISBC vs JNJ

ISBC vs JNJ: Dividend Comparison 2026

ISBC yields 21.83% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISBC wins by $116771762.60M in total portfolio value
10 years
ISBC
ISBC
● Live price
21.83%
Share price
$13.87
Annual div
$3.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$116771762.63M
Annual income
$115,752,943,300,661.28
Full ISBC calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ISBC vs JNJ

📍 ISBC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISBCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISBC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISBC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISBC
Annual income on $10K today (after 15% tax)
$1,855.20/yr
After 10yr DRIP, annual income (after tax)
$98,390,001,805,562.10/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ISBC beats the other by $98,390,001,801,576.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISBC + JNJ for your $10,000?

ISBC: 50%JNJ: 50%
100% JNJ50/50100% ISBC
Portfolio after 10yr
$58385881.33M
Annual income
$57,876,471,652,675.34/yr
Blended yield
99.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ISBC
Analyst Ratings
10
Buy
8
Hold
Consensus: Buy
Altman Z
0.9
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISBC buys
0
JNJ buys
0
No recent congressional trades found for ISBC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISBCJNJ
Forward yield21.83%2.13%
Annual dividend / share$3.03$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$116771762.63M$30.3K
Annual income after 10y$115,752,943,300,661.28$4,689.40
Total dividends collected$116704072.98M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ISBC vs JNJ ($10,000, DRIP)

YearISBC PortfolioISBC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,065$4,365.19$10,592$272.30+$4.5KISBC
2$28,412$12,292.02$11,289$357.73+$17.1KISBC
3$73,731$43,330.47$12,123$472.89+$61.6KISBC
4$289,072$210,180.23$13,141$629.86+$275.9KISBC
5$1,849,568$1,540,260.93$14,408$846.81+$1.84MISBC
6$20,399,656$18,420,617.67$16,021$1,151.60+$20.38MISBC
7$401,582,049$379,754,416.90$18,122$1,588.22+$401.56MISBC
8$14,403,041,597$13,973,348,804.96$20,930$2,228.20+$14403.02MISBC
9$952,167,596,512$936,756,342,002.87$24,792$3,191.91+$952167.57MISBC
10$116,771,762,628,929$115,752,943,300,661.28$30,274$4,689.40+$116771762.60MISBC

ISBC vs JNJ: Complete Analysis 2026

ISBCStock

Investors Bancorp, Inc. operates as the bank holding company for Investors Bank that provides various banking products and services to individuals and businesses in the United States. Its deposit products include savings, checking, and money market accounts. The company's loan portfolio comprises multi-family, commercial real estate, commercial and industrial, and construction loans; one-to four-family residential mortgage loans secured by one-to four-family residential real estate; and consumer and other loans primarily consisting of home equity loans, and home equity lines of credit, as well as various life insurance products. As of December 31, 2021, it operated through a network of 154 branches in New Jersey, New York, and Pennsylvania. Investors Bancorp, Inc. was founded in 1926 and is headquartered in Short Hills, New Jersey.

Full ISBC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ISBC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISBC vs SCHDISBC vs JEPIISBC vs OISBC vs KOISBC vs MAINISBC vs ABBVISBC vs MRKISBC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.